• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Tired-eye supplement introduced at the American Optometric Association

Article

At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Key Points

Burlington, NJ-At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Asthenopia is characterized by sensitivity to glare, headaches, sore eyes, and blurred vision. Fuji Chemical Industry of Japan's 11 human clinical studies of an all-natural antioxidant-astaxanthin-have shown significant positive results against asthenopia.

Astaxanthin acts as both a lipid-soluble and water-soluble antioxidant to reduce cellular inflammation while protecting cells. Supporting studies have shown that astaxanthin increases capillary blood flow and improves ciliary body function, as well as increases the endurance and recovery of muscles after overuse, exercise, and other forms of stress.

Related Videos
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Marjorie Rah, OD, PhD, FAAO
Selina McGee, OD, FAAO
© 2024 MJH Life Sciences

All rights reserved.